Final ID: P-214
Li Jason, Brody Jennifer, Wiggins Kerri, Swenson Brenton, Jensen Paul, Bockus Lee, Lemaitre Rozenn, Sootedehnia Nona
Angiotensin II vascular abnormalities in 32.5% of 3322 patients with essential hypertension(EH): Use of angiotensin II analogue, saralasin.Anderson Gunnar